C. PatrickReynoldsMDPhD
Pediatric Hematology & Oncology • Lubbock, TXCancer Center Director, School of Medicine, Texas Tech University Health Sciences Center
Dr. Reynolds is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 4th Street
STOP 9445
Lubbock, TX 79430Phone+1 806-743-1558
Education & Training
National Capital ConsortiumResidency, Pediatrics, 1980 - 1981
University of Texas Southwestern Medical SchoolClass of 1979
Certifications & Licensure
TX State Medical License 1979 - 2026
GA State Medical License 1988 - 2009
CA State Medical License 1989 - 2008
Clinical Trials
- Collecting and Storing Tissue From Young Patients With Cancer Start of enrollment: 2007 Mar 05
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 1182 citationsAnti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for NeuroblastomaAlice L. Yu, Andrew L. Gilman, M. Fevzi Ozkaynak, Wendy B. London, Susan G. Kreissman
The New England Journal of Medicine. 2010-09-30 - 607 citationsLong-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncol...Katherine K. Matthay, C. Patrick Reynolds, Robert C. Seeger, Hiroyuki Shimada, E. Stanton Adkins
Journal of Clinical Oncology. 2009-03-01 - 522 citationsDecreased expression of N- myc precedes retinoic acid-induced morphological differentiation of human neuroblastomaCarol J. Thiele, C P Reynolds, Mark A. Israel
Nature. 1985-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
